| pubmed-article:20819271 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20819271 | lifeskim:mentions | umls-concept:C0041296 | lld:lifeskim |
| pubmed-article:20819271 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
| pubmed-article:20819271 | lifeskim:mentions | umls-concept:C0039593 | lld:lifeskim |
| pubmed-article:20819271 | lifeskim:mentions | umls-concept:C0220908 | lld:lifeskim |
| pubmed-article:20819271 | lifeskim:mentions | umls-concept:C1514307 | lld:lifeskim |
| pubmed-article:20819271 | lifeskim:mentions | umls-concept:C1875713 | lld:lifeskim |
| pubmed-article:20819271 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:20819271 | pubmed:dateCreated | 2010-9-7 | lld:pubmed |
| pubmed-article:20819271 | pubmed:abstractText | Screening with chest X-ray and the Mantoux test (the tuberculin skin test [TST]) is compulsory for adult asylum seekers who arrive in Norway. In 2005-2006, we included 823 asylum seekers in a study of the QuantiFERON-TB Gold test (QFT-G), and followed them for 23-32 months. Eight subjects with a positive and one with a negative QFT-G test were diagnosed with tuberculosis (TB). The positive (PPV) and negative predictive values (NPV) for TB were respectively 3.3% and 99.8%. The PPV was 2.3% and the NPV 99.1% for TST >or= 15 mm, and the NPV was 99.5% for TST >or= 6 mm in combination with a negative QFT-G. | lld:pubmed |
| pubmed-article:20819271 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20819271 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20819271 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20819271 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20819271 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20819271 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20819271 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:20819271 | pubmed:issn | 1815-7920 | lld:pubmed |
| pubmed-article:20819271 | pubmed:author | pubmed-author:OftungFF | lld:pubmed |
| pubmed-article:20819271 | pubmed:author | pubmed-author:HeldalEE | lld:pubmed |
| pubmed-article:20819271 | pubmed:author | pubmed-author:WinjeB ABA | lld:pubmed |
| pubmed-article:20819271 | pubmed:author | pubmed-author:HarstadII | lld:pubmed |
| pubmed-article:20819271 | pubmed:author | pubmed-author:JacobsenG WGW | lld:pubmed |
| pubmed-article:20819271 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20819271 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:20819271 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20819271 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20819271 | pubmed:pagination | 1209-11 | lld:pubmed |
| pubmed-article:20819271 | pubmed:meshHeading | pubmed-meshheading:20819271... | lld:pubmed |
| pubmed-article:20819271 | pubmed:meshHeading | pubmed-meshheading:20819271... | lld:pubmed |
| pubmed-article:20819271 | pubmed:meshHeading | pubmed-meshheading:20819271... | lld:pubmed |
| pubmed-article:20819271 | pubmed:meshHeading | pubmed-meshheading:20819271... | lld:pubmed |
| pubmed-article:20819271 | pubmed:meshHeading | pubmed-meshheading:20819271... | lld:pubmed |
| pubmed-article:20819271 | pubmed:meshHeading | pubmed-meshheading:20819271... | lld:pubmed |
| pubmed-article:20819271 | pubmed:meshHeading | pubmed-meshheading:20819271... | lld:pubmed |
| pubmed-article:20819271 | pubmed:meshHeading | pubmed-meshheading:20819271... | lld:pubmed |
| pubmed-article:20819271 | pubmed:meshHeading | pubmed-meshheading:20819271... | lld:pubmed |
| pubmed-article:20819271 | pubmed:meshHeading | pubmed-meshheading:20819271... | lld:pubmed |
| pubmed-article:20819271 | pubmed:meshHeading | pubmed-meshheading:20819271... | lld:pubmed |
| pubmed-article:20819271 | pubmed:meshHeading | pubmed-meshheading:20819271... | lld:pubmed |
| pubmed-article:20819271 | pubmed:meshHeading | pubmed-meshheading:20819271... | lld:pubmed |
| pubmed-article:20819271 | pubmed:meshHeading | pubmed-meshheading:20819271... | lld:pubmed |
| pubmed-article:20819271 | pubmed:meshHeading | pubmed-meshheading:20819271... | lld:pubmed |
| pubmed-article:20819271 | pubmed:meshHeading | pubmed-meshheading:20819271... | lld:pubmed |
| pubmed-article:20819271 | pubmed:meshHeading | pubmed-meshheading:20819271... | lld:pubmed |
| pubmed-article:20819271 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20819271 | pubmed:articleTitle | Predictive values of QuantiFERON-TB Gold testing in screening for tuberculosis disease in asylum seekers. | lld:pubmed |
| pubmed-article:20819271 | pubmed:affiliation | Department of Public Health and General Practice, Norwegian University of Science and Technology, Trondheim, Norway. ingunn.harstad@ntnu.no | lld:pubmed |
| pubmed-article:20819271 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20819271 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20819271 | lld:pubmed |
